Production & Sales - Manufacturing

Novartis begins construction works at two RLT manufacturing facilities in US

Novartis has announced the commencement of construction on two new radioligand therapy (RLT) manufacturing facilities in the US, in a bid to expand its production and supply chain capabilities in the sector.

Merck launches GMP-compliant cell culture media line in China

Merck has initiated commercial manufacturing of its first Good Manufacturing Practices (GMP)-compliant manufacturing line for cell culture media (CCM) in China.

Rosemont acquires Pharma-Data to enhance global product development

Rosemont Pharmaceuticals, a developer of liquid medicines, has announced the acquisition of Pharma-Data, a research and development organisation based in Lavrion, Greece, enhancing its ability to develop products for worldwide market.

Sol-Gel, Beimei sign deal for TWYNEO commercialisation

Sol-Gel Technologies has entered into an asset purchase agreement with Shenzhen Beimei Pharmaceutical, granting the latter exclusive rights to commercialise Sol-Gel’s dermatology product TWYNEO in mainland China, Taiwan, Hong Kong, Macau, and Israel.  

Scorpius announces validation of microbial facilities

Scorpius Holdings, an integrated contract development and manufacturing organisation (CDMO), has confirmed the successful current Good Manufacturing Practice (cGMP) facility validation for microbial manufacturing. 

PharmaLogic launches new radiopharmaceutical facility in New York, US

PharmaLogic, a contract development and manufacturing organization (CDMO) and provider of radiopharmacy solutions, has announced the launch of its new radiopharmaceutical manufacturing and research facility at the Bronx in New York city, US.

IMA Life to build new pharma freeze-drying equipment production site

IMA Life North America is set to establish a new $30m facility in Tonawanda, New York, US, aimed at increasing its production capabilities for pharmaceutical freeze-drying equipment.

Biocon signs licensing and supply deal for diabetes drug in Brazil

Biocon, an India-based biopharmaceutical company, has entered into an exclusive licensing and supply agreement with Brazilian specialty pharmaceutical company Biomm for the commercialisation of Semaglutide (gOzempic), a drug used to improve glycemic control in adults with type-2 diabetes.

Merck to open new distribution centre in Brazil for Life Science sector

Merck has announced the opening of a new €20m ($21.7m) distribution centre in Cajamar, São Paulo, Brazil, for serving its Life Science customers in the region.